ELAVL1 and neoplasm: HuR protein has been recently reported to have a significant role in tumour angiogenesis, mainly supported by its association with the upregulation of VEGF-A and COX-2 in tumour endothelial cells, thus keeping an angiogenic switch on and activating angiogenic phenotype [13].